Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome) with a predominantly cardiac phenotype

Mol Genet Metab. 2011 Dec;104(4):695-9. doi: 10.1016/j.ymgme.2011.08.024. Epub 2011 Aug 27.

Abstract

We present here the first literature description of a predominantly cardiac phenotype in a patient homozygous for missense mutation p.R152W in the N-acetylogalactosamine-4-sulfatase (arylsulfatase B, ARSB) gene. An adult Caucasian woman, who displayed very few symptoms up to her late thirties, was diagnosed with mucopolysaccharidosis type VI (MPS VI) after her hospitalization due to acute heart failure originating mainly from valve disease. In addition to her cardiac phenotype some musculoskeletal involvement without other MPS characteristic features were found. Despite the common pharmacologic treatment and implementation of enzyme replacement therapy with galsulfase the patient died at the age of 38 years because of decompensation of chronic heart failure.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Fatal Outcome
  • Female
  • Glycosaminoglycans / urine
  • Heart Failure / diagnostic imaging*
  • Heart Failure / etiology
  • Heart Failure / genetics
  • Humans
  • Lumbosacral Region / diagnostic imaging
  • Mucopolysaccharidosis VI / complications
  • Mucopolysaccharidosis VI / diagnosis*
  • Mucopolysaccharidosis VI / genetics
  • Pelvis / diagnostic imaging
  • Phenotype
  • Radiography
  • Ultrasonography

Substances

  • Glycosaminoglycans